arBtrage CAPITALIZING MARKETS checking… Sign in

Allogene Therapeutics, Inc.

ALLO Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$1.88
▼ -7.8% Today
as of Jun 7, 07:08 ET
Last 30 days -14.16% Apr 28 → Jun 05
$1.84 $1.97 $2.10 $2.24 $2.37 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$2.01
High
$2.02
Low
$1.87
Volume
$8M
Avg Vol
$5M
Mkt Cap
$777M
P/E (TTM)
Beta
52w High
$4.46
52w Low
$0.98
Div Yield
Shares Out
$245M

Overview

52-week range
$0.98
$4.46
26% of range
Avg surprise (last 2)
+2.6%
Avg reaction (last 2)
-1.1%
50% positive
Latest IV / EM
96%
EM ±13.3% · $2 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.54$-0.45$-0.36$-0.27$-0.18 Actual $-0.54Actual $-0.37Actual $-0.38Actual $-0.35Actual $-0.32Actual $-0.28Est $-0.28Actual $-0.23Actual $-0.19Actual $-0.18Est $-0.19 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-66M$-61M$-55M$-49M$-43M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.18 $-0.19 +5.3% +35.7% +1.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.19 financials
Mon Jun 30, 2025Jun 2025 $-0.23 financials
Tue May 13, 2025Mar/2025 $-0.28 $-0.28 0.0% -3.4% earnings
Mon Sep 30, 2024Sep 2024 $-0.32 financials
Sun Jun 30, 2024Jun 2024 $-0.35 financials
Sun Mar 31, 2024Mar 2024 $-0.38 financials
Sat Sep 30, 2023Sep 2023 $-0.37 financials
Fri Jun 30, 2023Jun 2023 $-0.54 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$0$0$0$0$0
Cost of revenue
Gross profit
Operating income$-46M$-45M$-57M$-65M$-72M$-71M
Net income$-43M$-41M$-51M$-60M$-66M$-66M
EPS (diluted)$-0.18$-0.19$-0.23$-0.28$-0.32$-0.35

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$30M$52M$38M$52M$42M$75M$51M$171M
Inventory
Total current assets$273M$258M$261M$283M$292M$303M$304M$457M
Total assets$396M$416M$440M$471M$508M$549M$589M$647M
Long-term debt
Total liabilities$117M$123M$124M$126M$123M$127M$125M$132M
Total equity$279M$293M$315M$345M$385M$422M$464M$515M

Implied volatility — last 90 days

91%93%96%98%101% Jun 07 — IV 96% · EM ±13.3%

Sector peers